CE vs IDYA · rev $10.28B vs rev $7.0M
Celanese Corporation (CE) versus Ideaya Biosciences Inc (IDYA) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Ideaya Biosciences Inc (IDYA) is a biotechnology company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported IDYA revenue for 2024-12-31 was $7.0M. Net income was -$274.5M. Revenue was down 70.1% from 2023-12-31 to 2024-12-31. IDYA currently screens at market cap $2.96B.
CE currently screens at market cap $5.92B. IDYA currently screens at market cap $2.96B.
Not investment advice. Open the CE and IDYA stock pages for the full models.
Not investment advice.